scholarly journals Effects of Lifestyle Measures, Antiobesity Agents, and Bariatric Surgery on Serological Markers of Inflammation in Obese Patients

2010 ◽  
Vol 2010 ◽  
pp. 1-14 ◽  
Author(s):  
Konstantinos Tziomalos ◽  
Hariklia V. Dimitroula ◽  
Niki Katsiki ◽  
Christos Savopoulos ◽  
Apostolos I. Hatzitolios

Overweight and obesity are highly prevalent in developed countries and are also becoming more frequent in the developing world. Overweight and obese patients have elevated levels of several inflammatory markers and this inflammatory state might contribute to their increased vascular risk. We summarize the effects of lifestyle changes, antiobesity agents, and bariatric surgery on serological inflammatory markers in overweight and obese patients. Most studies showed a decrease in inflammation with all 3 interventions. However, it remains to be established whether the decrease in inflammatory markers induced by lifestyle changes or (where indicated) with antiobesity agents or bariatric surgery will translate into reduced vascular morbidity and mortality in overweight and obese patients.

2014 ◽  
Vol 99 (1) ◽  
pp. E53-E61 ◽  
Author(s):  
Julie Lasselin ◽  
Eric Magne ◽  
Cédric Beau ◽  
Patrick Ledaguenel ◽  
Sandra Dexpert ◽  
...  

Context: The inflammatory state of the adipose tissue is believed to contribute to systemic low-grade inflammation in obesity. Objective: This study assessed the relationship between adipose and circulating inflammatory markers as well as the influence of adipose inflammation on bariatric surgery-induced weight reduction. Design: This was a cross-sectional and longitudinal study (up to 14 mo). Setting: The study was conducted in the digestive/bariatric surgery department of the Tivoli and Jean Villar clinics, Bordeaux, France. Patients: Thirty-seven obese patients [body mass index (BMI) > 35–40 kg/m2)] seeking bariatric surgery were included. Twenty-eight of them were successively followed up at 1–3 months after surgery and 25 between 6 and 14 months after surgery. Main Outcome Measures: Fasting serum samples were collected before surgery to assess concentrations of inflammatory markers. Samples of visceral adipose tissue were extracted during surgery and gene expression of cytokines and immune cell markers were evaluated using quantitative RT-PCR. Pre- and postsurgery weight and BMI were collected. Results: Gene expression of several cytokines were strongly intercorrelated in the visceral adipose tissue. Adipose expression of macrophage and T cell markers were related to adipose expression of TNF-α and IL-1 receptor antagonist (P < .01) and to systemic levels of TNF-α (P < .01) and IL-6 (P < .05). A higher inflammatory state of the adipose tissue predicted a lower BMI reduction after surgery (P < .05), notably at early stages after surgery. Conclusions: These findings support the involvement of macrophages and T cells in adipose inflammation and provide new information regarding the role of the visceral adipose tissue in the inflammatory state of obesity and its impact on obesity treatment outcomes, such as surgery-induced weight loss.


2015 ◽  
Vol 13 (1) ◽  
pp. 29-35 ◽  
Author(s):  
Torunn Kristin Nestvold ◽  
Erik Waage Nielsen ◽  
Judith Krey Ludviksen ◽  
Hilde Fure ◽  
Anne Landsem ◽  
...  

Hypertension ◽  
2020 ◽  
Vol 76 (Suppl_1) ◽  
Author(s):  
Anna Oliveras ◽  
Marta Riera ◽  
Sara Alvarez ◽  
Albert Goday ◽  
Susana Vazquez ◽  
...  

Objective: to analyze AS before and 1 month (m) after bariatric surgery (BS), and search for pathophysiological mechanisms of changes (Δ). Methods: Forty-seven MO (72% women, 43% hypertensives, age 42.7±9.4 yr, BMI 42.2±5.4 Kg/m 2 , waist circumference 132.4±11.7 cm) were evaluated before and 1m after BS, with AS assessed by pulse-wave velocity (PWV), augmentation index at 75 beats/minute (AIx@75) and pulse pressure (PP) using a Mobile-O-Graph® device. 24h-ambulatory blood pressure (BP), RAAS components and several adipokines and inflammatory markers were also analyzed. Results: at 1m body weight (-13.6±4.32 Kg) and waist circumference (-9.2±5.3 cm) decreased (p<0.001). There were also significant Δ in BP, RAAS components and adipokines and inflammatory biomarkers (Table). Correlations were also explored. There was no correlation between Δ of any marker of AS and anthropometric changes nor with Δ of adipokines or inflammatory markers. Δ 24h-PP correlated with Δ 24h-systolic BP (coef. P. = 0.749; p <0.001) and with Δ of plasma renin activity (rho = -0.299; p = 0.049). Δ 24h-PWV correlated with Δ 24h-SBP (coef. P. = 0.587; p <0.001), with Δ 24h-DBP (coef. P. = 0.503; p <0.001) and with Δ ACE/ACE2 (coef. P. = -0.474; p =0.002). Δ AIx@75 correlated with Δ ACE (coef. P. = 0.316; p = 0.041). Conclusions: there is a decrease in AS one month after BS in obese patients. These changes correlated with Δ in both BP and the renin-angiotensin aldosterone system. ( * ) Data shown as median [interquartile range]


Author(s):  
G. Catanzaro ◽  
T. Filardi ◽  
C. Sabato ◽  
A. Vacca ◽  
S. Migliaccio ◽  
...  

Abstract Background Obesity, characterized by an increased amount of adipose tissue, is a metabolic chronic alteration which has reached pandemic proportion. Lifestyle changes are the first line therapy for obesity and a large variety of dietary approaches have demonstrated efficacy in promoting weight loss and improving obesity-related metabolic alterations. Besides diet and physical activity, bariatric surgery might be an effective therapeutic strategy for morbid obese patients. Response to weight-loss interventions is characterised by high inter-individual variability, which might involve epigenetic factors. microRNAs have critical roles in metabolic processes and their dysregulated expression has been reported in obesity. Aim The aim of this review is to provide a comprehensive overview of current studies evaluating changes in microRNA expression in obese patients undergoing lifestyle interventions or bariatric surgery. Results A considerable number of studies have reported a differential expression of circulating microRNAs before and after various dietary and bariatric surgery approaches, identifying several candidate biomarkers of response to weight loss. Significant changes in microRNA expression have been observed at a tissue level as well, with entirely different patterns between visceral and subcutaneous adipose tissue. Interestingly, relevant differences in microRNA expression have emerged between responders and non-responders to dietary or surgical interventions. A wide variety of dysregulated microRNA target pathways have also been identified, helping to understand the pathophysiological mechanisms underlying obesity and obesity-related metabolic diseases. Conclusions Although further research is needed to draw firm conclusions, there is increasing evidence about microRNAs as potential biomarkers for weight loss and response to intervention strategies in obesity.


2021 ◽  
Vol 22 (9) ◽  
pp. 4798
Author(s):  
Gopi Battineni ◽  
Getu Gamo Sagaro ◽  
Nalini Chintalapudi ◽  
Francesco Amenta ◽  
Daniele Tomassoni ◽  
...  

Overweight and obesity are key risk factors of cardiovascular disease (CVD). Obesity is currently presented as a pro-inflammatory state with an expansion in the outflow of inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), alongside the expanded emission of leptin. The present review aimed to evaluate the relationship between obesity and inflammation and their impacts on the development of cardiovascular disease. A literature search was conducted by employing three academic databases, namely PubMed (Medline), Scopus (EMBASE), and the Cumulative Index to Nursing and Allied Health Literature (CINAHL). The search presented 786 items, and by inclusion and exclusion filterers, 59 works were considered for final review. The Newcastle–Ottawa Scale (NOS) method was adopted to conduct quality assessment; 19 papers were further selected based on the quality score. Obesity-related inflammation leads to a low-grade inflammatory state in organisms by upregulating pro-inflammatory markers and downregulating anti-inflammatory cytokines, thereby contributing to cardiovascular disease pathogenesis. Because of inflammatory and infectious symptoms, adipocytes appear to instigate articulation and discharge a few intense stage reactants and carriers of inflammation. Obesity and inflammatory markers are strongly associated, and are important factors in the development of CVD. Hence, weight management can help prevent cardiovascular risks and poor outcomes by inhibiting inflammatory mechanisms.


2018 ◽  
Vol 13 (2) ◽  
pp. 93 ◽  
Author(s):  
C Richard Conti ◽  

The entire world is becoming overweight. Most people are motivated to try to lose weight for cosmetic reasons. Weight loss can decrease health risk factors and possibly improve prognosis. Weight loss can be difficult in people who are trying to stop smoking, as they tend to gain weight. Many weight loss systems are available and are not inexpensive. Athletes who are obese and fit must lose weight after retirement or suffer the consequences related to risk factors. Bariatric surgery seems to be the best way for morbidly obese patients to lose weight, assuming that they adhere to principles of risk factor modulation. Weight-loss medications work in most patients who also comply with lifestyle changes, but these drugs have a number of side-effects.


Hypertension ◽  
2019 ◽  
Vol 74 (Suppl_1) ◽  
Author(s):  
Anna Oliveras ◽  
David Benito ◽  
Susana Vázquez ◽  
Maria Vera ◽  
Sara Outon ◽  
...  

Author(s):  
Giovanna Scartabelli ◽  
Ferruccio Santini

The increasing prevalence of overweight and obesity represents an important challenge, worldwide, for the various health systems. The obesity pandemic is associated with the rapid economic growth which has led to relevant lifestyle changes most of them favoring a chronically positive energy balance. On a global scale, between 1980 and 2013, the cumulative prevalence of overweight and obesity in adults has increased from 29% to 37%. This increase concerns also early youth and childhood: the prevalence of overweight and obesity has reached 23% in developed countries and 13% in developing countries. In Italy, a national surveillance program established in 2007 and financed by the Ministry of Health / CCM (Center for Disease Control and Prevention), provides the updated epidemiological framework for the analysis of the prevalence of weight excess and risky behaviors in primary school children. At the time of the last assessment, overweight children, were 20.9%, while obese children were 9.8%. The obesity pandemic is a maladaptive response to an environment enriched in energy availability and which is not exposed anymore to famine episodes. Individual susceptibility to obesity largely depends on the genetic background on which the environment exerts variable pressure. Obesity, in more than 95% of cases, has a multifactorial pathogenesis and can be considered the prototype of what is generally called "a complex phenotype". In facts, unlike diseases with Mendelian transmission, in which there is substantially a direct correlation between genotype and phenotype, obesity represents the result of an interaction between multiple genetic traits, environmental factor and socio-cultural habits. According to the "thrifty genotype" hypothesis, our genetic heritage has evolved in conditions of reduced food availability, selecting "thrifty genes" favoring the deposition of adipose tissue. In recent decades, the wide availability of high energy food has increased rapidly and the "thrifty" genotype has become a promoter for the development of obesity. Although many gene variants that can favor weight accumulation have been identified, a relevant portion of the genetic makeup underlying obesity remains unexplained until today. Beside allelic variants, quite common in the general population, probably exerting small effects on the risk of obesity, an additional contribution may derive from epigenetic modifications developed by living in an obesogenic environment.


SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A9-A9
Author(s):  
Sophie Hirsch ◽  
Jane Gaultney ◽  
Patricia Crane

Abstract Introduction Despite positive secondary prevention strategies post myocardial infarction (MI), including statin use and lifestyle changes, 32% of the annual MIs are recurrent (MIR). As coronary heart disease is related to atherosclerosis, a chronic inflammatory process, and sleep is associated with cardiovascular disease and innate immunity, understanding the role of sleep and inflammation and MIR is important in developing interventions to improve sleep, reduce inflammation, and delay or prevent MIR. This study aimed to explore the role of sleep quality and inflammatory markers on MIRs. Methods We conducted a secondary analysis of cross-sectional data of individuals (N=156) having at least one or more MIs within the last 3 to 7 years. Using the hypothalamus-pituitary-adrenal axis model (Irwin, 2019), we tested sleep quality (Pittsburgh Sleep Quality Index [PSQI]) predicting MIR, using inflammatory markers (hs C-Reactor Protein [CRP], Interleukin-1ß [IL-1ß] and Tumor Necrosis Factor alpha [TNFα]) as the simultaneous indirect paths. Race, sex and body mass index (BMI) were also examined using moderated mediation. Results The sample ranged in age from 34 to 92 (M = 65.37, SD = 12.13), BMI averaged 31.11 (SD = 7.34), and was comprised of mostly male (57.1%) and White adults (67.9%). PSQI predicted only IL-1ß (ß= .02; p &lt; .01). IL-1ß predicted MIR (ß = .80, p = .05). The direct effect of PSQI to MIR was not significant (p =.12), the indirect path via IL-1ß was. This relationship was not moderated by race, sex, nor BMI. Conclusion IL-1ß is an inflammatory marker elevated after acute MI which does not reflect our selected sample. Inflammation may be an important marker of risk for MIR in those with poor sleep quality. Future studies should examine other markers of inflammation and sleep in those with MIR. Support (if any):


Sign in / Sign up

Export Citation Format

Share Document